Drug    DrugBank | All Description Patterns💬 Info on mouse-over

16 / 17,542 descriptions

No. Drug (Description in trials) DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY
On map, Yellow: Drug target genes
Disease ID
 1  2-cda, 2-chloro-2'-deoxy-beta-d-adenosine  Adenosine  [2] D00045, D01370 💬  [5] ADORA1, ADORA2A, ADORA2B, ADORA3, RRM1 💬  [17] Alcoholism, Calcium signaling pathway, Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Purine metabolism, Pyrimidine metabolism, Rap1 signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Sphingolipid signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway  [1] 13 💬 
 2  2-cda, 2-chloro-2'-deoxy-ß-d-adenosine  Adenosine  [2] D00045, D01370 💬  [5] ADORA1, ADORA2A, ADORA2B, ADORA3, RRM1 💬  [17] Alcoholism, Calcium signaling pathway, Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Purine metabolism, Pyrimidine metabolism, Rap1 signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Sphingolipid signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway  [1] 13 💬 
 3  2-cda, 2-chloro-2?-deoxy-beta-d-adenosine  Adenosine  [2] D00045, D01370 💬  [5] ADORA1, ADORA2A, ADORA2B, ADORA3, RRM1 💬  [17] Alcoholism, Calcium signaling pathway, Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Purine metabolism, Pyrimidine metabolism, Rap1 signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Sphingolipid signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway  [1] 13 💬 
 4  2-cda, 2-chloro-2?-deoxy-ß-d-adenosine  Adenosine  [2] D00045, D01370 💬  [5] ADORA1, ADORA2A, ADORA2B, ADORA3, RRM1 💬  [17] Alcoholism, Calcium signaling pathway, Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Purine metabolism, Pyrimidine metabolism, Rap1 signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Sphingolipid signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway  [1] 13 💬 
 5  2-cda, 2-chloro-2’-deoxy-beta-d-adenosine  Adenosine  [2] D00045, D01370 💬  [5] ADORA1, ADORA2A, ADORA2B, ADORA3, RRM1 💬  [17] Alcoholism, Calcium signaling pathway, Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Purine metabolism, Pyrimidine metabolism, Rap1 signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Sphingolipid signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway  [1] 13 💬 
 6  2-cda, 2-chloro-2’-deoxy-ß-d-adenosine  Adenosine  [2] D00045, D01370 💬  [5] ADORA1, ADORA2A, ADORA2B, ADORA3, RRM1 💬  [17] Alcoholism, Calcium signaling pathway, Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Purine metabolism, Pyrimidine metabolism, Rap1 signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Sphingolipid signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway  [1] 13 💬 
 7  2-chloro-2'-deoxy-beta-d-adenosine (2-cda)  Adenosine  [2] D00045, D01370 💬  [5] ADORA1, ADORA2A, ADORA2B, ADORA3, RRM1 💬  [17] Alcoholism, Calcium signaling pathway, Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Purine metabolism, Pyrimidine metabolism, Rap1 signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Sphingolipid signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway  [1] 13 💬 
 8  2-chloro-2'-deoxy-ß-d-adenosine (2-cda)  Adenosine  [2] D00045, D01370 💬  [5] ADORA1, ADORA2A, ADORA2B, ADORA3, RRM1 💬  [17] Alcoholism, Calcium signaling pathway, Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Purine metabolism, Pyrimidine metabolism, Rap1 signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Sphingolipid signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway  [1] 13 💬 
 9  2-chloro-2?-deoxy-beta-d-adenosine  Adenosine  [1] D00045 💬  [4] ADORA1, ADORA2A, ADORA2B, ADORA3 💬  [12] Alcoholism, Calcium signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Sphingolipid signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway  [1] 13 💬 
 10  2-chloro-2?-deoxy-ß-d-adenosine  Adenosine  [1] D00045 💬  [4] ADORA1, ADORA2A, ADORA2B, ADORA3 💬  [12] Alcoholism, Calcium signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Sphingolipid signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway  [1] 13 💬 
 11  2-chloro-2’-deoxy-beta-d-adenosine  Adenosine  [1] D00045 💬  [4] ADORA1, ADORA2A, ADORA2B, ADORA3 💬  [12] Alcoholism, Calcium signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Sphingolipid signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway  [1] 13 💬 
 12  2-chloro-2’-deoxy-beta-d-adenosine (2-cda)  Adenosine  [2] D00045, D01370 💬  [5] ADORA1, ADORA2A, ADORA2B, ADORA3, RRM1 💬  [17] Alcoholism, Calcium signaling pathway, Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Purine metabolism, Pyrimidine metabolism, Rap1 signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Sphingolipid signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway  [1] 13 💬 
 13  2-chloro-2’-deoxy-ß-d-adenosine  Adenosine  [1] D00045 💬  [4] ADORA1, ADORA2A, ADORA2B, ADORA3 💬  [12] Alcoholism, Calcium signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Sphingolipid signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway  [1] 13 💬 
 14  2-chloro-2’-deoxy-ß-d-adenosine (2-cda)  Adenosine  [2] D00045, D01370 💬  [5] ADORA1, ADORA2A, ADORA2B, ADORA3, RRM1 💬  [17] Alcoholism, Calcium signaling pathway, Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Purine metabolism, Pyrimidine metabolism, Rap1 signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Sphingolipid signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway  [1] 13 💬 
 15  Adenosine  Adenosine  [1] D00045 💬  [4] ADORA1, ADORA2A, ADORA2B, ADORA3 💬  [12] Alcoholism, Calcium signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Sphingolipid signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway  [3] 13, 58, 65 💬 
 16  Autologous ex vivo gene therapy products based on the efs lv encoding for the human adenosine deaminase (ada) gene (efs-ada lv)  Adenosine  [1] D00045 💬  [4] ADORA1, ADORA2A, ADORA2B, ADORA3 💬  [12] Alcoholism, Calcium signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Sphingolipid signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway  [1] 65 💬